NEOVACS SA (UK) Financials


EUR 0.19  0.005  2.70%   

We recommend to make use of NEOVACS SA NEOVACS fundamental analysis to find out if markets are now mispricing the entity. Strictly speaking you can employ it to find out if NEOVACS SA NEOVACS is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We are able to break down and analyze data for twenty-one available fundamentals for NEOVACS SA, which can be compared to its peers in the industry. To ensure the equity is not overpriced, please verify all NEOVACS SA NEOVACS financials, including its revenue, ebitda, and the relationship between the price to book and gross profit .
With this module, you can analyze NEOVACS financials for your investing period. You should be able to track the changes in NEOVACS SA individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past NEOVACS SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of NEOVACS SA's financial statements are interrelated, with each one affecting the others. For example, an increase in NEOVACS SA's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 73
NEOVACS SA NEOVACS has more than 73 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for NEOVACS SA stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in NEOVACS SA's official financial statements usually reflect NEOVACS SA's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of NEOVACS SA NEOVACS. For example, before you start analyzing numbers published by NEOVACS accountants, it's critical to develop an understanding of what NEOVACS SA's liquidity, profitability, and earnings quality are in the context of the NEOVACS SA NEOVACS space in which it operates.
Please note, the presentation of NEOVACS SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NEOVACS SA's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in NEOVACS SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NEOVACS SA NEOVACS. Please utilize our Beneish M Score to check the likelihood of NEOVACS SA's management to manipulate its earnings.

NEOVACS SA Company Summary

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. Neovacs S.A. was founded in 1993 and is based in Paris, France. NEOVACS SA is traded on London Stock Exchange in UK.
InstrumentUK Stock View All
ExchangeLondon Stock Exchange
Business Address3-5, Impasse Reille
Phone33 1 53 10 93 00
CurrencyEUR - Euro
You should never invest in NEOVACS SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NEOVACS Stock, because this is throwing your money away. Analyzing the key information contained in NEOVACS SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

NEOVACS SA Key Financial Ratios

Generally speaking, NEOVACS SA's financial ratios allow both analysts and investors to convert raw data from NEOVACS SA's financial statements into concise, actionable information that can be used to evaluate the performance of NEOVACS SA over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NEOVACS SA NEOVACS reports annually and quarterly.

NEOVACS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining NEOVACS SA's current stock value. Our valuation model uses many indicators to compare NEOVACS SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NEOVACS SA competition to find correlations between indicators driving NEOVACS SA's intrinsic value. More Info.
NEOVACS SA NEOVACS is number one stock in shares owned by insiders category among related companies. It is number one stock in shares owned by institutions category among related companies producing about  2.00  of Shares Owned by Institutions per Shares Owned by Insiders. . Comparative valuation analysis is a catch-all model that can be used if you cannot value NEOVACS SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NEOVACS SA's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NEOVACS SA's earnings, one of the primary drivers of an investment's value.

NEOVACS SA Market Fundamentals

 Change(%) 2.70 

About NEOVACS SA Financials

What exactly are NEOVACS SA Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include NEOVACS SA's income statement, its balance sheet, and the statement of cash flows. Potential NEOVACS SA investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although NEOVACS SA investors may use each financial statement separately, they are all related. The changes in NEOVACS SA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NEOVACS SA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as NEOVACS SA is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of NEOVACS grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
Please continue to Trending Equities. Note that the NEOVACS SA NEOVACS information on this page should be used as a complementary analysis to other NEOVACS SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for NEOVACS Stock

When running NEOVACS SA NEOVACS price analysis, check to measure NEOVACS SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NEOVACS SA is operating at the current time. Most of NEOVACS SA's value examination focuses on studying past and present price action to predict the probability of NEOVACS SA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move NEOVACS SA's price. Additionally, you may evaluate how the addition of NEOVACS SA to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences